BIND Therapeutics (BIND) Soars: Stock Adds 9.1% in Session

BIND Therapeutics, Inc. (BIND) was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the healthcare company, as the stock is now up nearly 46%.

In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.

BIND Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Affymetrix Inc. (AFFX), ANI Pharmaceuticals, Inc. (ANIP) and Actelion Ltd. (ALIOF). While Affymetrix carries a Zacks Rank #2 (Buy), ANI Pharmaceuticals and Actelion sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



BIND THERAPEUTICS INC (BIND): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research